NEW YORK, NY — August 3, 2026 (ACI Newswire) – The healthcare technology and biopharmaceutical sectors exited the first half of 2026 with a material rebound in venture funding and a sharper focus on manufacturing infrastructure, driven by high-conviction investments in…
